Log in to search using one of your social media accounts:

 

Johnson & Johnson wins cancer lawsuit in California
Meanwhile, J&J faces lawsuits by around 5,500 plaintiffs nationally asserting talc-related claims, largely saying it failed to warn women about the risk of ovarian cancer from the products. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2017 Category: Consumer Health News Source Type: news

Computer program finds new uses for old drugs
(Case Western Reserve University) Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy. In a recent study published in Oncogene, the researchers successfully translated DrugPredict results into the laboratory, and showed common pain medications--like aspirin--can kill patient-derived epithelial ovarian cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 16, 2017 Category: Cancer & Oncology Source Type: news

NICE approves breakthrough breast cancer drugs
New class of cancer treatment drugs approved for NHS Related items fromOnMedica The genetics of breast cancer Ovarian cancer drug may help stall breast cancer Experts recommend anastrozole for postmenopausal women with family history of breast cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 16, 2017 Category: UK Health Source Type: news

Symptoms of ovarian cancer: Seven signs you could have the disease
OVARIAN cancer is a disease which does display a number of symptoms - which could speed up treatment. Sarah Greene - who lost her mother to the disease - has joined This Morning hosts Holly Willoughby and Phillip Schofield to raise awareness for the symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - November 15, 2017 Category: Consumer Health News Source Type: news

Cancer symptoms: These THREE types are on the rise - do YOU know the signs?
CANCER survival rates are improving but rates of certain cancers are increasing. Do you know the symptoms of skin, ovarian and mouth cancers? (Source: Daily Express - Health)
Source: Daily Express - Health - November 11, 2017 Category: Consumer Health News Source Type: news

Know the Signs of Ovarian Cancer and Your Risks
Title: Know the Signs of Ovarian Cancer and Your RisksCategory: Health NewsCreated: 11/9/2017 12:00:00 AMLast Editorial Review: 11/10/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 10, 2017 Category: Cancer & Oncology Source Type: news

Mayo Clinic Q and A: Diagnosing ovarian cancer
DEAR MAYO CLINIC: Why is ovarian cancer almost always diagnosed when it?s already late-stage? Are there any tests that can help health care providers detect ovarian cancer earlier? Who?s at risk for this disease? ANSWER: Ovarian cancer is hard to detect in its early stages, because symptoms are usually either nonexistent or they are vague. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 10, 2017 Category: Databases & Libraries Source Type: news

Know the Signs of Ovarian Cancer and Your Risks
Source: HealthDay Related MedlinePlus Pages: Ovarian Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 9, 2017 Category: Consumer Health News Source Type: news

Know the Signs of Ovarian Cancer and Your Risks
THURSDAY, Nov. 9, 2017 -- About 22,440 American women will learn they have ovarian cancer this year, and more than 14,000 will die from the disease, according to the American Cancer Society. Often called a " silent killer, " ovarian cancer is the 9th... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2017 Category: General Medicine Source Type: news

Know the Signs of Ovarian Cancer and Your Risks
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - November 9, 2017 Category: Cancer & Oncology Source Type: news

Fighting cancer with cancer: 3-D cultured cells could drive precision therapy
(University of Michigan) Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 8, 2017 Category: Cancer & Oncology Source Type: news

Hertfordshire teen's missed periods were ovarian cancer
As well as not having menstruated in 6 months, Amy, from Hertfordshire, developed thick facial hair. She was told she had two-and-a-half times the normal level of testosterone in her blood. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2017 Category: Consumer Health News Source Type: news

Teen shocked missed periods were OVARIAN CANCER
As well as not having menstruated in 6 months, Amy, from Hertfordshire, developed thick facial hair. She was told she had two-and-a-half times the normal level of testosterone in her blood. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2017 Category: Consumer Health News Source Type: news

Ovarian cancer news: Blood test could DIAGNOSE deadly type EARLY before symptoms
CANCER of the ovaries often doesn ’t show symptoms until the later stages. However, a blood test could soon be used to diagnose the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - November 1, 2017 Category: Consumer Health News Source Type: news

Computed Tomography Features Vary Based on BRCA Status
Differences seen between BRCA - mutant versus BRCA wild - type high - grade serous ovarian cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 31, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Radiology, Journal, Source Type: news

New Study Shows Improved Peritoneal Mesothelioma Survival
Patients with malignant peritoneal mesothelioma who completed a novel, two-stage cytoreduction and intraperitoneal chemotherapy regimen had a median overall survival of 6.65 years. Almost 30 percent of those patients had a survival estimate of more than 10 years after the second stage of treatment, according to a study published recently in the Annals of Surgical Oncology. The study involved 113 patients from New York-Presbyterian Hospital/Columbia University Medical Center. Researchers demonstrated the therapeutic advances concerning this once unbeatable cancer. While progress has been slow in improving current pleural me...
Source: Asbestos and Mesothelioma News - October 31, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: Columbia University Medical Center Dr. Michael Kluger Dr. Paul Sugarbaker HIPEC for peritoneal mesothelioma New York-Presbyterian Hospital peritoneal mesothelioma treatment Source Type: news

Lichfield mum is diagnosed with incurable ovarian cancer
Jessica Bourne, 39, of Lichfield, Staffordshire, became ill within months of her 16-year-old boy, Jaye Camacho, being declared cancer-free following a three-year battle. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news

Mother-of-three is diagnosed with incurable ovarian cancer
Jessica Bourne, 39, of Lichfield, Staffordshire, became ill within months of her 16-year-old boy, Jaye Camacho, being declared cancer-free following a three-year battle. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news

New blood test developed to diagnose ovarian cancer
(Brigham and Women's Hospital) Investigators from Brigham and Women's Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately. The team has identified a network of circulating microRNAs -- small, non-coding pieces of genetic material -- that are associated with risk of ovarian cancer and can be detected from a blood sample. Their findings are published online in eLife. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 31, 2017 Category: Cancer & Oncology Source Type: news

New Blood Test Developed to Diagnose Ovarian Cancer
Non-invasive diagnostic tool being developed to measure circulating microRNAs to predict ovarian cancer with specificity. (Source: BWH News)
Source: BWH News - October 31, 2017 Category: Hospital Management Source Type: news

New Blood Test Developed to Diagnose Ovarian Cancer
Non-invasive diagnostic tool being developed to measure circulating microRNAs to predict ovarian cancer with specificity. (Source: BWH for Journalists)
Source: BWH for Journalists - October 31, 2017 Category: Research Source Type: news

' Important' Progress in Gynecologic Cancers: ESMO 2017'Important' Progress in Gynecologic Cancers: ESMO 2017
Dr Banerjee discusses advances in ovarian and cervical cancers presented at ESMO 2017.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 30, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

'Kidpreneur' raises nearly $10K for ovarian cancer research
How this 9-year-old kidpreneur raised $10K for cancer research (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 27, 2017 Category: American Health Authors: Angela Gonzales Source Type: news

(HC RP 11-3-17) 'Kidpreneur' raises nearly $10K for ovarian cancer research
How this 9-year-old kidpreneur raised $10K for cancer research (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 27, 2017 Category: Pharmaceuticals Authors: Angela Gonzales Source Type: news

(HC RP 11-3-17) 'Kidpreneur' raises nearly $10K for ovarian cancer research
How this 9-year-old kidpreneur raised $10K for cancer research (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 27, 2017 Category: Biotechnology Authors: Angela Gonzales Source Type: news

NovoCure rises on Q3 EPS, sales beat
Shares in Novocure (NSDQ:NVCR) are on the rise today after the medical device maker topped revenue and losses-per-share expectations on Wall Street with its 3rd quarter earnings results. The St. Helier, N.J.-based company posted losses of $11.5 million, or 13¢ per share, on sales of $50.1 million for the 3 months ended September 30, seeing losses on the bottom-line shrink 65.8% while sales grew 131.2% compared with the same period during the previous fiscal year. Losses per share for the quarter came in under the 17¢ consensus on Wall Street, while sales beat the $43.6 million expectations on The Street. &ld...
Source: Mass Device - October 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup NovoCure Source Type: news

FDA accepts Roche ’s supplemental Biologics License Application for Avastin as a front-line treatment for women with advanced ovarian cancer
Roche announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for Avastin ® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin alone, for the front-line treatment of women with advanced ovarian cancer. (Source: Roche Investor Update)
Source: Roche Investor Update - October 26, 2017 Category: Pharmaceuticals Source Type: news

Mutation in fallopian tube lesions may help catch ovarian cancer years earlier
(University of Pennsylvania School of Medicine) Screening for tumor cells in the fallopian tubes of women at high-risk for ovarian cancer may help detect the cancer years before it develops further, suggests a new study published online this week in Nature Communications. The new study traces the origins of high-grade serous ovarian carcinoma, the most frequent type of ovarian cancer that is often diagnosed at advanced stages, back to fallopian tube lesions known as 'p53 signatures' and serous tubal intraepithelial carcinomas (STICs) that harbor the TP53 gene mutations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2017 Category: Cancer & Oncology Source Type: news

What You May Not Know About Ovarian Cancer
Title: What You May Not Know About Ovarian CancerCategory: Health NewsCreated: 10/24/2017 12:00:00 AMLast Editorial Review: 10/25/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 25, 2017 Category: Cancer & Oncology Source Type: news

Ovarian cancer symptoms that just 1% of us know
A survey of more than 1,000 English women found that just 1 per cent were aware that needing to urinate more is a symptom of ovarian cancer according to a leading charity. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2017 Category: Consumer Health News Source Type: news

What You May Not Know About Ovarian Cancer
Most cases start in the fallopian tubes, not the ovaries, study suggests (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 24, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Research, News, Source Type: news

What You May Not Know about Ovarian Cancer
Most cases start in the fallopian tubes, not the ovaries, study suggests Source: HealthDay Related MedlinePlus Pages: Ovarian Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 24, 2017 Category: Consumer Health News Source Type: news

What You May Not Know About Ovarian Cancer
TUESDAY, Oct. 24, 2017 -- In a report that will likely surprise many women, researchers say most cases of ovarian cancer originate in the fallopian tubes, not the ovaries. " Based on a better understanding of its origins, our study suggests new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 24, 2017 Category: General Medicine Source Type: news

Plasma beam that blasts ovarian cancer
A new treatment destroys ovarian cancer using a beam of energy. Executive PA Terry Middlecott, 62, a grandmother from Surbiton, Surrey, was one of the first to undergo it, as she tells PAT HAGAN. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2017 Category: Consumer Health News Source Type: news

What You May Not Know About Ovarian Cancer
Most cases start in the fallopian tubes, not the ovaries, study suggests (Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news

Courts Reverse Johnson ’ s Baby Powder Settlements for Nearly $500 Million
The decisions came in two cases against Johnson& Johnson, in which women claimed they developed ovarian cancer after using the powder for years. (Source: NYT Health)
Source: NYT Health - October 23, 2017 Category: Consumer Health News Authors: CHRISTINA CARON Tags: Ovarian Cancer Women and Girls Johnson & talcum powder baby powder Suits and Litigation (Civil) Liability for Products Eva Echeverria Jacqueline Fox Maren E. Nelson Los Angeles (Calif) Missouri Source Type: news

Courts Reverse Johnson ’ s Baby Powder Judgments for Nearly $500 Million
The decisions came in two cases against Johnson& Johnson, in which women claimed they developed ovarian cancer after using baby powder for years. (Source: NYT Health)
Source: NYT Health - October 23, 2017 Category: Consumer Health News Authors: CHRISTINA CARON Tags: Ovarian Cancer Women and Girls Johnson & talcum powder baby powder Suits and Litigation (Civil) Liability for Products Eva Echeverria Jacqueline Fox Maren E. Nelson Los Angeles (Calif) Missouri Source Type: news

Courts Reverse Johnson Baby Powder Settlements for Nearly $500 Million
The decisions came in two cases against Johnson& Johnson, in which women claimed they developed ovarian cancer after using the powder for years. (Source: NYT Health)
Source: NYT Health - October 23, 2017 Category: Consumer Health News Authors: CHRISTINA CARON Tags: Ovarian Cancer Women and Girls Johnson & talcum powder baby powder Suits and Litigation (Civil) Liability for Products Eva Echeverria Jacqueline Fox Maren E. Nelson Los Angeles (Calif) Missouri Source Type: news

Ovarian cancer starts 6.5 years before it turns deadly
A new study from Johns Hopkins Medicine has found that ovarian cancer usually begins in the fallopian tubes and that it takes 6.5 years to develop. (Source: the Mail online | Health)
Source: the Mail online | Health - October 23, 2017 Category: Consumer Health News Source Type: news

Judge overturns record verdict in Johnson & Johnson talcum powder trial
Judges in two separate cases have ruled in favor of pharma giant Johnson& Johnson, overturning large financial judgments awarded to plaintiffs who believe the company's Baby Powder and Shower to Shower powder products caused their ovarian cancer. One award was to a California woman for $417 million, and another was to an Alabama woman for $72 million. (Source: CNN.com - Health)
Source: CNN.com - Health - October 23, 2017 Category: Consumer Health News Source Type: news

Judge overturns record verdict in talcum powder trial
Judges in two separate cases have ruled in favor of pharma giant Johnson& Johnson, overturning large financial judgments awarded to plaintiffs who believe the company's Baby Powder and Shower to Shower powder products caused their ovarian cancer. One award was to a California woman for $417 million, and another was to an Alabama woman for $72 million. (Source: CNN.com - Health)
Source: CNN.com - Health - October 23, 2017 Category: Consumer Health News Source Type: news

Scientists track ovarian cancers to site of origin: Fallopian tubes
(Johns Hopkins Medicine) Some scientists have suspected that the most common form of ovarian cancer may originate in the fallopian tubes, the thin fibrous tunnels that connect the ovaries to the uterus. Now, results of a study of nine women suggest that the genomic roots of many ovarian tumors may indeed arise in the fallopian tubes, potentially providing insights into the origin of ovarian cancer and suggesting new ways for prevention and intervention of this disease (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2017 Category: Cancer & Oncology Source Type: news

Judge overturns $417M award against Johnson & Johnson in ovarian cancer case
A judge in Los Angeles has tossed out a $417-million US jury award to a woman who claimed she developed ovarian cancer by using Johnson & Johnson talc-based baby powder for feminine hygiene. (Source: CBC | Health)
Source: CBC | Health - October 21, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

$417M jury award against Johnson & Johnson thrown out by judge
A California woman claimed she developed ovarian cancer by using Johnson& Johnson talc-based baby powder for feminine hygiene (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 21, 2017 Category: Consumer Health News Source Type: news

California judge tosses $417 million talc cancer verdict against Johnson & Johnson
(Reuters) - A California judge on Friday threw out a $417 million verdict against Johnson& Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using its talc-based products like Johnson's Baby Powder for feminine hygiene. (Source: Reuters: Health)
Source: Reuters: Health - October 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Having More CD8+ Tumor-infiltrating Lymphocytes May Boost Ovarian Cancer Survival Having More CD8+ Tumor-infiltrating Lymphocytes May Boost Ovarian Cancer Survival
In women with high-grade serous ovarian carcinomas, increasing levels of CD8+ tumor-infiltrating lymphocytes (TILs) show a robust, dose-dependent survival benefit, according to a large observational study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 19, 2017 Category: Pathology Tags: Hematology-Oncology News Source Type: news

NHS 'not screening for some forms of cancer costing lives'
Ovarian Cancer Action said around one in six cases are linked to the mutated BRCA gene – famously carried by Angelina Jolie – which significantly increases their risk. (Source: the Mail online | Health)
Source: the Mail online | Health - October 19, 2017 Category: Consumer Health News Source Type: news

Ovarian cancer charity says women are dying because NHS isn't testing for disease
WOMEN are dying from ovarian cancer due to a lack of genetic testing that should be available on the NHS, experts are warning. (Source: Daily Express - Health)
Source: Daily Express - Health - October 18, 2017 Category: Consumer Health News Source Type: news

To Prevent Ovarian Cancer, Focus on the Fallopian Tube To Prevent Ovarian Cancer, Focus on the Fallopian Tube
New data support the rationale to focus on the distal fallopian tube when considering surgical or medical approaches to prevent high-grade serous ovarian cancer, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Talcum Powder/Ovarian Cancer Lawsuit Award Tossed
Award in Missouri case set aside upon appeal. Does not affect larger California award in similar suit. (Source: WebMD Health)
Source: WebMD Health - October 18, 2017 Category: Consumer Health News Source Type: news